Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Related Posts Fortune Bay: Maximizing Shareholder Value in Gold and Uranium September 9, 2025 North American Mining Conferences Presentation September 9, 2025 JLL Signs Non-Binding LOI to List McDermitt on a US Exchange September 9, 2025